Preladenant Completed Phase 2 Trials for Motor Skills Disorders / Brain Disorders / Central Nervous System Disorder / Neurodegenerative Disorders / Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00537017Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
NCT00406029Dyskinesia in Parkinson's Disease (Study P04501)